[Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
D000328:Adult; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005750:Gastric Juice / Q000378:metabolism; D006146:Guanidines / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
D001570:Benzodiazepinones; D006146:Guanidines; D006635:Histamine H2 Antagonists; D010879:Piperazines; D002927:Cimetidine
Efficacité de traitements anti-sécrétoires combinés (cimétidine et pirenzépin) dans le syndrome de Zollinger-Ellison.